Table 3.
CTL (n = 12) | MAE (n = 12) | HAE (n = 12) | MRE (n = 12) | |
---|---|---|---|---|
NREM Sleep | ||||
Stage 1 (%) | ||||
Baseline | 3.4 ± 2 | 4.8 ± 6 | 5.7 ± 5 | 3.7 ± 2 |
Post-exercise | 3.3 ± 2 | 4.4 ± 3 | 5.9 ± 3 | 3.8 ± 2 |
Stage 2 (%) | ||||
Baseline | 55.3 ± 10 | 54.4 ± 9 | 55.3 ± 9 | 58.0 ± 5 |
Post-exercise | 56.9 ± 6 | 56.6 ± 8 | 59.1 ± 12 | 59.4 ± 10 |
Stages 3 and 4 (%) | ||||
Baseline | 23.1 ± 7 | 23.5 ± 6 | 18.8 ± 7 | 20.4 ± 5 |
Post-exercise | 19.2 ± 7 | 22.0 ± 12 | 15.5 ± 8 | 19.4 ± 6 |
REM Sleep (%) | ||||
Baseline | 18.1 ± 5 | 17.3 ± 8 | 20.2 ± 8 | 17.9 ± 6 |
Post-exercise | 20.5 ± 6 | 18.7 ± 5 | 19.4 ± 7 | 17.5 ± 6 |
MRE, moderate-intensity resistance exercise; MAE, moderate-intensity aerobic exercise; HAE, high-intensity aerobic exercise; CTL, control.
Repeated-measures ANOVA, significant results, p < 0.05; data are expressed as mean ± SD;
* baseline ≠ post-exercise.